Mo1111 RNASET2 RISK VARIANT AS A NOVEL BLOOD BASED DIAGNOSTIC FOR DEFINING A SEVERE CD PATIENT POPULATION RESPONSIVE TO DIRECTED RNASET2 THERAPEUTICS
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI